| Aisha Chin, | |
|
525 El Camino Real, Millbrae, CA 94030-2030 | |
| (650) 652-3477 | |
| Not Available |
| Full Name | Aisha Chin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 525 El Camino Real, Millbrae, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447683735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 67541 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aisha Chin, 525 El Camino Real, Millbrae, CA 94030-2030 Ph: (650) 652-3477 | Aisha Chin, 525 El Camino Real, Millbrae, CA 94030-2030 Ph: (650) 652-3477 |
News Archive
Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government support is lacking. But there may be a solution to this vaccine crisis with the ability to save at-risk populations, according to a perspective piece written by physicians based at Princeton University, University of Pennsylvania and the Wellcome Trust.
Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology.
Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet.
A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to new research in the American Heart Association's journal Hypertension.
New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.
› Verified 8 days ago
Dr. Diane N Nguyen, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 El Camino Real, Millbrae, CA 94030 Phone: 650-652-3477 Fax: 650-652-3921 | |
Miss Janice M Ng, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1206 Hillcrest Blvd, Millbrae, CA 94030 Phone: 415-722-6431 | |
Yuanjun Wang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45 S El Camino Real, Millbrae, CA 94030 Phone: 650-697-3970 | |
Miranda Choy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 El Camino Real, Millbrae, CA 94030 Phone: 650-742-2627 | |
Ms. Wei-lin Chang-lubiano, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7a Hazel Ave, Millbrae, CA 94030 Phone: 415-430-8527 | |
Carmen Chung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45 S El Camino Real, Millbrae, CA 94030 Phone: 650-697-3970 | |
Ashley Lee, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45 S El Camino Real, Millbrae, CA 94030 Phone: 408-316-1625 |